These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16892691)

  • 1. Why do oncologists prescribe--or not prescribe--conventional chemotherapy to geriatric patients with metastatic non-small cell lung cancer?
    Jatoi A; Hillman S; Stella P; Rowland K; Morton R; Dakhil S
    J Support Oncol; 2006; 4(7):311-2. PubMed ID: 16892691
    [No Abstract]   [Full Text] [Related]  

  • 2. The lung cancer paradox: time for action.
    Rintoul RC; Sethi T
    Thorax; 2002 Oct; 57 Suppl 2(Suppl 2):II57-II63. PubMed ID: 12364713
    [No Abstract]   [Full Text] [Related]  

  • 3. Can a single pill replace doublet chemotherapy in first-line therapy of advanced non-small cell lung cancer?
    Bunn PA
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5919-20. PubMed ID: 17062660
    [No Abstract]   [Full Text] [Related]  

  • 4. A survey of Japanese thoracic oncologists' perception of diagnostic and treatment strategies for EGFR mutant or EML4-ALK fusion non-small cell lung cancer.
    Hotta K; Kiura K; Tabata M; Takigawa N; Tanimoto M; Ueoka H
    Chest; 2014 Dec; 146(6):e222-e225. PubMed ID: 25451370
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-small-cell lung cancer patients unsuitable for first-line chemotherapy: a new category of patients for clinical studies?
    Soto Parra HJ; Latteri F; Cavina R; De Vincenzo F; Zucali PA; Campagnoli E; Santoro A
    J Am Geriatr Soc; 2005 Jun; 53(6):1078-80. PubMed ID: 15935045
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer.
    Viswanathan A; Pillot G; Govindan R
    Lung Cancer; 2005 Dec; 50(3):417-8. PubMed ID: 16129510
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer drugs. Smart weapons prove tough to design.
    Couzin J
    Science; 2002 Oct; 298(5593):522-5. PubMed ID: 12386312
    [No Abstract]   [Full Text] [Related]  

  • 8. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
    Pfister DG; Johnson DH; Azzoli CG; Sause W; Smith TJ; Baker S; Olak J; Stover D; Strawn JR; Turrisi AT; Somerfield MR;
    J Clin Oncol; 2004 Jan; 22(2):330-53. PubMed ID: 14691125
    [No Abstract]   [Full Text] [Related]  

  • 9. [Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?].
    Greillier L; Barlesi F
    Rev Mal Respir; 2012 Jan; 29(1):4-6. PubMed ID: 22240212
    [No Abstract]   [Full Text] [Related]  

  • 10. First-line combination chemotherapy for advanced non-small cell lung cancer: the Eastern Cooperative Oncology Group and Southwest Oncology Group experience.
    Sandler A
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):44-51. PubMed ID: 10566611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-stage lung cancer findings end a debate, put focus on next steps.
    McNeil C
    J Natl Cancer Inst; 2004 Jul; 96(14):1054-5. PubMed ID: 15265961
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.
    Lilenbaum R; Axelrod R; Thomas S; Dowlati A; Seigel L; Albert D; Witt K; Botkin D
    J Clin Oncol; 2008 Feb; 26(6):863-9. PubMed ID: 18281658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erlotinib in previously treated non-small-cell lung cancer.
    Shepherd FA; Rodrigues Pereira J; Ciuleanu T; Tan EH; Hirsh V; Thongprasert S; Campos D; Maoleekoonpiroj S; Smylie M; Martins R; van Kooten M; Dediu M; Findlay B; Tu D; Johnston D; Bezjak A; Clark G; Santabárbara P; Seymour L;
    N Engl J Med; 2005 Jul; 353(2):123-32. PubMed ID: 16014882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of non-small-cell lung cancer (NSCLC) in elderly patients].
    Westeel V
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S35-4S38. PubMed ID: 15687992
    [No Abstract]   [Full Text] [Related]  

  • 15. [Limitations of palliative chemotherapy, application to lung cancer: the point of view of hospital pharmacists].
    Demange C; Thiébaux I
    Bull Cancer; 2003 Mar; 90(3):284-8. PubMed ID: 12801830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.
    Herbst RS; Prager D; Hermann R; Fehrenbacher L; Johnson BE; Sandler A; Kris MG; Tran HT; Klein P; Li X; Ramies D; Johnson DH; Miller VA;
    J Clin Oncol; 2005 Sep; 23(25):5892-9. PubMed ID: 16043829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.
    Eberhard DA; Johnson BE; Amler LC; Goddard AD; Heldens SL; Herbst RS; Ince WL; Jänne PA; Januario T; Johnson DH; Klein P; Miller VA; Ostland MA; Ramies DA; Sebisanovic D; Stinson JA; Zhang YR; Seshagiri S; Hillan KJ
    J Clin Oncol; 2005 Sep; 23(25):5900-9. PubMed ID: 16043828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preoperative chemotherapy in patients with non-small cell lung cancer].
    Adachi A; Hayashi A; Hayashida R; Hattori R; Nagamatsu Y; Nasu K; Iwanaga D; Takagi K; Ono H; Kakegawa T
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):673-5. PubMed ID: 8385907
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy for non-small-cell lung cancer--new horizons.
    Reed CE; Carlson LS; Schiff RD; Seymore CH; Thompson KA
    J S C Med Assoc; 1990 May; 86(5):270-4. PubMed ID: 2160565
    [No Abstract]   [Full Text] [Related]  

  • 20. Restoration of gefitinib efficacy following chemotherapy in a patient with metastatic non-small cell lung cancer.
    Li XD; Geng YT; Wu CP; Shen H; Sun J; Shu YQ; Yin YM
    Onkologie; 2010; 33(8-9):466-9. PubMed ID: 20838064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.